Literature DB >> 19093931

Survival in elderly persons with Down syndrome.

Antonia M W Coppus1, Heleen M Evenhuis, Gert-Jan Verberne, Frank E Visser, Ben A Oostra, Piet Eikelenboom, Willem A van Gool, A Cecile J W Janssens, Cornelia M van Duijn.   

Abstract

The longer life expectancy now experienced by persons with Down syndrome (DS) makes it necessary to know the factors influencing survival in older persons with this syndrome. In a prospective longitudinal cohort study of dementia and mortality, 506 persons with DS aged 45 and older were followed for a mean of 4.5 years (range 0.0-7.6 years). Cognitive and social functioning were tested at baseline and annual follow-up. The diagnosis of dementia was determined according to a standardized protocol. Cox proportional hazards modeling was used for survival analysis. Relative preservation of cognitive and functional ability is associated with better survival in this study population. Clinically, the most important disorders in persons with DS that are related to mortality are dementia, mobility restrictions, visual impairment, and epilepsy but not cardiovascular diseases. Also, level of intellectual disability and institutionalization are associated with mortality.

Entities:  

Mesh:

Year:  2008        PMID: 19093931     DOI: 10.1111/j.1532-5415.2008.01999.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  20 in total

1.  An observational study of adults with Down syndrome eating independently.

Authors:  Christina H Smith; Yafen Teo; Sarah Simpson
Journal:  Dysphagia       Date:  2013-07-17       Impact factor: 3.438

Review 2.  Aneuploidy and skeletal health.

Authors:  Archana Kamalakar; John R Harris; Kent D McKelvey; Larry J Suva
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

3.  Cause of death in adults with Down syndrome in the United States.

Authors:  Scott D Landes; J Dalton Stevens; Margaret A Turk
Journal:  Disabil Health J       Date:  2020-06-10       Impact factor: 2.554

4.  Candidate gene analysis for Alzheimer's disease in adults with Down syndrome.

Authors:  Joseph H Lee; Annie J Lee; Lam-Ha Dang; Deborah Pang; Sergey Kisselev; Sharon J Krinsky-McHale; Warren B Zigman; José A Luchsinger; Wayne Silverman; Benjamin Tycko; Lorraine N Clark; Nicole Schupf
Journal:  Neurobiol Aging       Date:  2017-05-03       Impact factor: 4.673

5.  Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome).

Authors:  Kirby M Sherman; Diarra K Williams; Casey A Welsh; Alexis M Cooper; Alyssa Falck; Shannon Huggins; Rihana S Bokhari; Dana Gaddy; Kent D McKelvey; Lindsay A Dawson; Larry J Suva
Journal:  Bone       Date:  2022-06-15       Impact factor: 4.626

6.  Prevalence of Common Disease Conditions in a Large Cohort of Individuals With Down Syndrome in the United States.

Authors:  Brian Chicoine; Anne Rivelli; Veronica Fitzpatrick; Laura Chicoine; Gengjie Jia; Andrey Rzhetsky
Journal:  J Patient Cent Res Rev       Date:  2021-04-19

7.  Prevalence of Mental Health Conditions Among 6078 Individuals With Down Syndrome in the United States.

Authors:  Anne Rivelli; Veronica Fitzpatrick; Sagar Chaudhari; Laura Chicoine; Gengjie Jia; Andrey Rzhetsky; Brian Chicoine
Journal:  J Patient Cent Res Rev       Date:  2022-01-17

8.  Survival among people with Down syndrome: a nationwide population-based study in Denmark.

Authors:  Jin Liang Zhu; Henrik Hasle; Adolfo Correa; Diana Schendel; J M Friedman; Jørn Olsen; Sonja A Rasmussen
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

Review 9.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

10.  Factors determining disease duration in Alzheimer's disease: a postmortem study of 103 cases using the Kaplan-Meier estimator and Cox regression.

Authors:  R A Armstrong
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.